The PPCD1 mouse: characterization of a mouse model for posterior polymorphous corneal dystrophy and identification of a candidate gene.
The PPCD1 mouse, a spontaneous mutant that arose in our mouse colony, is characterized by an enlarged anterior chamber resulting from metaplasia of the corneal endothelium and blockage of the iridocorneal angle by epithelialized corneal endothelial cells. The presence of stratified multilayered corneal endothelial cells with abnormal patterns of cytokeratin expression are remarkably similar to those observed in human posterior polymorphous corneal dystrophy (PPCD) and the sporadic condition, iridocorneal endothelial syndrome. Affected eyes exhibit epithelialized corneal endothelial cells, with inappropriate cytokeratin expression and proliferation over the iridocorneal angle and posterior cornea. We have termed this the "mouse PPCD1" phenotype and mapped the mouse locus for this phenotype, designated "Ppcd1", to a 6.1 Mbp interval on Chromosome 2, which is syntenic to the human Chromosome 20 PPCD1 interval. Inheritance of the mouse PPCD1 phenotype is autosomal dominant, with complete penetrance on the sensitive DBA/2J background and decreased penetrance on the C57BL/6J background. Comparative genome hybridization has identified a hemizygous 78 Kbp duplication in the mapped interval. The endpoints of the duplication are located in positions that disrupt the genes Csrp2bp and 6330439K17Rik and lead to duplication of the pseudogene LOC100043552. Quantitative reverse transcriptase-PCR indicates that expression levels of Csrp2bp and 6330439K17Rik are decreased in eyes of PPCD1 mice. Based on the observations of decreased gene expression levels, association with ZEB1-related pathways, and the report of corneal opacities in Csrp2bp(tm1a(KOMP)Wtsi) heterozygotes and embryonic lethality in nulls, we postulate that duplication of the 78 Kbp segment leading to haploinsufficiency of Csrp2bp is responsible for the mouse PPCD1 phenotype. Similarly, CSRP2BP haploinsufficiency may lead to human PPCD.
Shen
Anna L
AL
McArdle Laboratory for Cancer Research, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin, United States of America. alshen@wisc.edu
O'Leary
Kathleen A
KA
Dubielzig
Richard R
RR
Drinkwater
Norman
N
Murphy
Christopher J
CJ
Kasper
Charles B
CB
Bradfield
Christopher A
CA
D000818:Animals; D033481:Chromosomes, Mammalian / Q000235:genetics; D055028:Comparative Genomic Hybridization; D003316:Corneal Diseases / Q000235:genetics* / Q000473:pathology; D004195:Disease Models, Animal; D019573:Epithelium, Corneal / Q000473:pathology; D006801:Humans; D008297:Male; D051379:Mice; D010641:Phenotype
Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1754-9
14745032
Hum Mol Genet. 2002 May 15;11(10):1195-206
12015279
FASEB J. 2005 Aug;19(10):1232-44
16051690
J Biol Chem. 2002 Feb 22;277(8):6536-41
11742006
Cornea. 2002 Nov;21(8):787-91
12410038
Cornea. 2006 Sep;25(8):956-9
17102674
Optometry. 2009 Aug;80(8):431-6
19635434
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):1934-9
15914606
J Biol Chem. 2008 Dec 5;283(49):33808-15
18838386
Exp Eye Res. 2007 Apr;84(4):680-6
17289024
Am J Med Genet A. 2007 Nov 1;143A(21):2549-56
17935237
Invest Ophthalmol Vis Sci. 2005 May;46(5):1599-603
15851557
Cornea. 2009 Aug;28(7):801-7
19574904
Mol Vis. 2008 Jan 16;14:71-80
18253095
Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8424-8
8378314
Genet Med. 2007 Apr;9(4):228-34
17438387
Hum Mol Genet. 1995 Dec;4(12):2395-8
8634716
Arch Ophthalmol. 1977 Sep;95(9):1529-37
302697
Mol Cell Biol. 2009 Mar;29(5):1176-88
19103755
Cell Mol Life Sci. 2009 Mar;66(5):773-87
19011757
Hum Mol Genet. 1995 Mar;4(3):485-8
7795607
Exp Mol Med. 2007 Aug 31;39(4):450-7
17934332
Invest Ophthalmol Vis Sci. 1995 Apr;36(5):820-7
7706030
Front Biosci. 2003 May 01;8:d687-713
12700042
Am J Med Genet A. 2004 Nov 1;130A(4):372-7
15384081
Br J Ophthalmol. 2004 Mar;88(3):428-32
14977782
Am J Ophthalmol. 2003 Apr;135(4):461-70
12654361
Semin Ophthalmol. 2007 Oct-Dec;22(4):241-6
18097987
Mol Vis. 2009 Dec 03;15:2544-53
19997581
Hum Mol Genet. 2001 Oct 1;10(21):2415-23
11689488
Arch Ophthalmol. 2001 Apr;119(4):624-5
11296040
Invest Ophthalmol Vis Sci. 1997 Aug;38(9):1896-901
9286281
Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4480-4
16303937
Invest Ophthalmol Vis Sci. 2008 May;49(5):1843-9
18436818
Am J Hum Genet. 2005 Nov;77(5):694-708
16252232
Am J Hum Genet. 2010 Jan;86(1):45-53
20036349